Dermal dendrocytes participate in the cellular pathology of experimental acute graft-versus-host disease

Journal of Cutaneous Pathology

Volumn 25, Issue 8, 1998, Pages 426-434

  Yoo, Young H ^a   Park, Bong S ^b   Whitaker Menezes, Diana ^c   Korngold, Robert ^c   Murphy, George F ^c  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8A; CD8 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DENDRITIC CELL; DERMIS; DONOR; ELECTRON MICROSCOPY; GRAFT VERSUS HOST REACTION; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MICROVASCULATURE; MOUSE; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PINOCYTOSIS; SKIN CAPILLARY; SKIN CELL; T LYMPHOCYTE; TIGHT JUNCTION;

ACUTE DISEASE; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; DENDRITIC CELLS; DERMIS; DISEASE MODELS, ANIMAL; EAR; GRAFT VS HOST DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED CBA; MICROSCOPY, IMMUNOELECTRON; T-LYMPHOCYTES; TRANSGLUTAMINASES;

EID: 0031692524     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1998.tb01769.x     Document Type: Article

References (44)

1. Santos GW, Hess AD, Vogelsang GB. Graft-versus-host reactions and disease. Imnumol Rev 1985: 88: 169.
2. Korngold R, Sprent J. Lethal graft-versus-host disease following bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978: 148: 1687.
3. Korngold R, Sprent J. Variable capacity of L3T4+ T cells to cause graft-versus-host disease across minor histocompatibility antigens. J Exp Med 1987: 165: 1552.
4. Hamilton BL. L3T4-positive T cells participate in the induction of graft-versus-host disease in response to minor histocompatibility antigens. J Immunol 1987: 139: 2511.
5. Ferrara JLM, Guillen FJ, Sleckman B, Burakoff SJ, Murphy GF. Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease. J Invest Dermatol 1986: 86: 371.
6. Ferrara JLM, Marion A, McIntyte JF, Murphy GF, Burakoff SJ. Amelioration of acute graft vs host disease due to minor histocompatibility antigens by in vivo administration of anti-interleukin 2 receptor antibody. J Immunol 1986: 137: 1874.
7. Murphy GF, Whitaker D, Sprent J, Korngold R. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elecited by either CD4+ or CD8+ effector cells. Am J Pathol 1991: 138: 983.
8. Sale GE, Shulman HM, McDonald GB, Shulman HM, Thomas ED. Gastrointestinal graft-versus-host disease in man. A clinicopathological study of the rectal biopsy. Am J Surg Pathol 1979: 3: 291.
9. Volc-Platzer B, Rappersberger K, Mosberger I, et al. Sequential immunohistologic analysis of the skin following allogeneic bone marrow trasnplantation. J Invest Dermatol 1988: 91: 162.
10. Murphy GF, Bronstein BR, Knowles RW, Bhan AK. Ultrastructural documentation of M241 glycoprotein on dendritic and endothelial cells in normal human skin. Lab Invest 1985: 52: 264.
11. Nickoloff BJ, Griffiths CEM. Not all spindle-shaped cells embedded in a collagenous stroma are fibroblasts: recognition of the 'collagen-associated dendrophage'. J Cutan Pathol 1989: 16: 266.
12. Streilein JW. Antigen-presenting cells in the induction of contact hypersensitivity in mice: Evidence that Langerhans cells are sufficient, but not required. J Invest Dermatol 1989: 93: 443.
13. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973: 137: 1142.
14. Bowers WE, Goodell EM. Dendritic cell ontogeny. Res Immunol 1989: 140: 880.
15. Nussenzweig MC, Witner MD, Nogueira N. A comparison of dendritic cells and macrophages. In: Forster O, Landy M, eds. Heterogeneity of mononuclear phagocytes. San Diego: Academic Press, 1981: 189.
16. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med 1974: 139: 380.
17. Steinman RM, Witmer M. Lymphoid dendritic cells are potent stimulators of primary mixed leukocyte reaction in mice. Proc Natl Acad Sci USA 1978: 75: 5132.
18. Steinman RM, Kaplan G, Witmer MD, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice V. Purification of spleen dendritic cells, new surrface markers and maintenance in vitro. J Exp Med 1979: 149: 1.
19. Steinman RM, Nussenzweig MC. Dendritic cells: Features and functions. Immunol Rev 1980: 53: 127.
20. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991: 9: 271.
21. Thorbecke GJ, Silberberg-Sinakin I, Flotte TJ. Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol 1980: 75: 32.
22. Headington JT. The Dermal Dendrocyte. In: Callen JP, Dahl MV, Golitz LE, Rasmussen JE, Stegman SJ, eds. Advances in Dermatology. Chicago: Year Book Medical Publishers Inc, 1986: 159.
23. Cerio R, Griffiths CEM, Cooper KD, Nickoloff BJ, Headington JT. Characterization of DDs positive dermal dendritic cells in normal and inflamed skin. Br J Dermaltol 1989: 121: 421.
24. Headington JT, Cerio R. Dendritic cells and the dermis. Am J Dermatopathol 1990: 12: 217.
25. Sueki H, Whitaker D, Buchsbaum M, Murphy GF. Novel Interactions between dermal clendrocyles and mast cells in human skin. Lab Invest 1993: 69: 160.
26. Tse Y, Cooper KD. Cutaneous dermal Ia+ cells are capable of initiating delayed type hypersensitivity responses. J Invest Dermatol 1990: 94: 267.
27. Sontheimer RD. Perivascular dendritic macrophages as immunobiological constituents of the human dermal microvascular unit. J Invest Dermatol 1989: 93(suppl): 96S.
28. Bruce J, Symington F W, McKearn TJ, Sprent J. A monoclonal antibody discriminating between subsets of T and B cells. J Immunol 1981: 127: 2496.
29. Ceredig R, Lowenthal J, Nabholz M, MacDonald HR. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature (London) 1985: 314: 98.
30. Cerio R, Spaull J, Wilson Jones E. Histiocytoma cutis: a tumor of dermal dendrocytes (dermal dendrocytoma). Br J Dermatol 1989: 120: 197.
31. Chen LL, Adams JC, Steinman RM. Anatomy of germinal centers in mouse spleen, with special reference to 'follicular dendritic cells'. J Cell Biol 1978: 77: 148.
32. Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. J Biol Chem 1973: 248: 1395.
33. Cerio R, Spaull JR, Wilson Jones E. Identification of factor XIIIa in cutaneous tissue. Histopathology 1988: 13: 362.
34. Walsh LJ, Goerdt S, Pober JS, Sueki H, Murphy GF. MS-1 sinusoidal endothelial antigen is expressed by Factor XII-Ia+ HLA-DR+ dermal perivascular dendritic cells. Lab Invest 1991: 65: 732.
35. Arrese Estrada J, Piérard GE. Factor-XIIIa-positive dendrocytes and the dermal microvascular unit. Dermatologica 1990: 180: 51.
36. Cerio R, Rao BK, Spaull J, Wilson Jones E. An immunohistochemical study of fibrous papule of the nose: 25 cases. J Cutan Pathol 1989: 16: 194.
37. Nemeth AJ, Penneys NS, Bernstein HB. Fibrous papule: A tumor of fibrohistiocytic cells that contain Factor XIIIa. J Am Acad Dermatol 1988: 19: 1102.
38. Penneys NS. Factor XIII expression in the skin: Observations and a hypothesis. J Am Acad Dermatol 1990: 22: 484.
39. Piérard GE, Arrese-Estrada J, Pirard-Franchimont C, Deleixhe-Mauhin F. Is there link between dendrocytes, fibrosis und sclerosis? Dermatologica 1990: 181: 264.
40. Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 1987: 166: 1280.
41. McCarthy P, Abhyankar S, Neben S, et al. Inhibition of interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 1991: 78: 1915.
42. Synkes M, Romick ML, Sachs DH. Interleukin-2 prevents graft-vs.-host disease without diminishing the graft-leukemia effect of allogeneic lymphocytes. Proc Natl Acad Sci USA 1990: 87: 5633.
43. Murphy GF, Hirohiko Sueki, Cory Teusher, Diana Whitaker, Robert Korngold. Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease. J Invest Dermatol 1994: 102: 451.
44. Tamaki K, Yasaka N, Chang CH, et al. Identification and characterization of novel dermal Thy-1 antigen-bearing dendritic cells in murine skin. J Invest Dermatol 1996: 106: 571.